Baronsmead VCT 3 plc
4 August 2009
The Board of Baronsmead VCT 3 plc is pleased to announce that Anthony Townsend
has been appointed as a Director of the Company with effect from 4 August 2009.
Mr Townsend has over 40 years experience in financial services and in industry.
He is Chairman of British & American Investment Trust plc, F&C Global Smaller
Companies plc, Finsbury Growth and Income Trust plc and iimia Investment Trust,
a Non-executive director of Hansa Capital Limited and the Finsbury Worldwide
Pharmaceutical Trust plc. He previously was a director of Rea Brothers Group
plc and was Chairman of the Association of Investment Companies.
Mark Cannon Brookes, Chairman of Baronsmead VCT 3 plc, commented:
"Anthony brings a wealth of experience working in investment banking and fund
management and this appointment further strengthens the Board."
No additional details need to be disclosed in respect of paragraphs 9.6.13(1)
to (6) of the Financial Services Authority Listing Rules.
For further information:
Paul Forster, Company Secretary, Baronsmead AIM VCT plc Tel: 020 7506 5652
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.